The role of tyrosine kinase inhibitors in the treatment of renal cell carcinoma with brain metastases
Gespeichert in:
| Veröffentlicht in: | Journal of B.U. ON. 2016-01, Vol.21 (1), p.281-282 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 282 |
|---|---|
| container_issue | 1 |
| container_start_page | 281 |
| container_title | Journal of B.U. ON. |
| container_volume | 21 |
| creator | Aytekin, Aydin Ciltas, Aydin Sahinli, Hayriye Benekli, Mustafa |
| description | |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_1780509979</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1780509979</sourcerecordid><originalsourceid>FETCH-LOGICAL-p211t-b52445efc8c9d57a1e505446b1513f2c25fd2fb334689451154d13ea87cd53063</originalsourceid><addsrcrecordid>eNo1kMtqwzAQRbVoaUKaXyhadmPQ6GV7WUJfEMgmXRvZHmO1tuRKCiV_X4Wml2HuLM4Mw70hawBWFkxztSLbGD9Zlmag6-qOrHjJNCjN1wSPI9LgJ6R-oOkcfLQO6Zd1JiK1brStTT7EPNKUyRTQpBlduuABnZloh1NuJnTW-dnQH5tG2gaTF2ZMJubCeE9uBzNF3F59Qz5eno-7t2J_eH3fPe2LhQOkolVcSoVDV3V1r0oDqJiSUregQAy842ro-dAKIXVVSwWgZA8CTVV2vRJMiw15_Lu7BP99wpia2cbLg8ahP8UGyoopVtdlndGHK3pqZ-ybJdjZhHPzH434BdtiX7M</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1780509979</pqid></control><display><type>article</type><title>The role of tyrosine kinase inhibitors in the treatment of renal cell carcinoma with brain metastases</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Aytekin, Aydin ; Ciltas, Aydin ; Sahinli, Hayriye ; Benekli, Mustafa</creator><creatorcontrib>Aytekin, Aydin ; Ciltas, Aydin ; Sahinli, Hayriye ; Benekli, Mustafa</creatorcontrib><identifier>ISSN: 1107-0625</identifier><identifier>PMID: 27061562</identifier><language>eng</language><publisher>Greece</publisher><subject>Brain Neoplasms - secondary ; Carcinoma, Renal Cell - drug therapy ; Carcinoma, Renal Cell - secondary ; Humans ; Kidney Neoplasms - drug therapy ; Kidney Neoplasms - pathology ; Protein Kinase Inhibitors - therapeutic use ; Protein-Tyrosine Kinases - antagonists & inhibitors</subject><ispartof>Journal of B.U. ON., 2016-01, Vol.21 (1), p.281-282</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27061562$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Aytekin, Aydin</creatorcontrib><creatorcontrib>Ciltas, Aydin</creatorcontrib><creatorcontrib>Sahinli, Hayriye</creatorcontrib><creatorcontrib>Benekli, Mustafa</creatorcontrib><title>The role of tyrosine kinase inhibitors in the treatment of renal cell carcinoma with brain metastases</title><title>Journal of B.U. ON.</title><addtitle>J BUON</addtitle><subject>Brain Neoplasms - secondary</subject><subject>Carcinoma, Renal Cell - drug therapy</subject><subject>Carcinoma, Renal Cell - secondary</subject><subject>Humans</subject><subject>Kidney Neoplasms - drug therapy</subject><subject>Kidney Neoplasms - pathology</subject><subject>Protein Kinase Inhibitors - therapeutic use</subject><subject>Protein-Tyrosine Kinases - antagonists & inhibitors</subject><issn>1107-0625</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1kMtqwzAQRbVoaUKaXyhadmPQ6GV7WUJfEMgmXRvZHmO1tuRKCiV_X4Wml2HuLM4Mw70hawBWFkxztSLbGD9Zlmag6-qOrHjJNCjN1wSPI9LgJ6R-oOkcfLQO6Zd1JiK1brStTT7EPNKUyRTQpBlduuABnZloh1NuJnTW-dnQH5tG2gaTF2ZMJubCeE9uBzNF3F59Qz5eno-7t2J_eH3fPe2LhQOkolVcSoVDV3V1r0oDqJiSUregQAy842ro-dAKIXVVSwWgZA8CTVV2vRJMiw15_Lu7BP99wpia2cbLg8ahP8UGyoopVtdlndGHK3pqZ-ybJdjZhHPzH434BdtiX7M</recordid><startdate>201601</startdate><enddate>201601</enddate><creator>Aytekin, Aydin</creator><creator>Ciltas, Aydin</creator><creator>Sahinli, Hayriye</creator><creator>Benekli, Mustafa</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>201601</creationdate><title>The role of tyrosine kinase inhibitors in the treatment of renal cell carcinoma with brain metastases</title><author>Aytekin, Aydin ; Ciltas, Aydin ; Sahinli, Hayriye ; Benekli, Mustafa</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p211t-b52445efc8c9d57a1e505446b1513f2c25fd2fb334689451154d13ea87cd53063</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Brain Neoplasms - secondary</topic><topic>Carcinoma, Renal Cell - drug therapy</topic><topic>Carcinoma, Renal Cell - secondary</topic><topic>Humans</topic><topic>Kidney Neoplasms - drug therapy</topic><topic>Kidney Neoplasms - pathology</topic><topic>Protein Kinase Inhibitors - therapeutic use</topic><topic>Protein-Tyrosine Kinases - antagonists & inhibitors</topic><toplevel>online_resources</toplevel><creatorcontrib>Aytekin, Aydin</creatorcontrib><creatorcontrib>Ciltas, Aydin</creatorcontrib><creatorcontrib>Sahinli, Hayriye</creatorcontrib><creatorcontrib>Benekli, Mustafa</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of B.U. ON.</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Aytekin, Aydin</au><au>Ciltas, Aydin</au><au>Sahinli, Hayriye</au><au>Benekli, Mustafa</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The role of tyrosine kinase inhibitors in the treatment of renal cell carcinoma with brain metastases</atitle><jtitle>Journal of B.U. ON.</jtitle><addtitle>J BUON</addtitle><date>2016-01</date><risdate>2016</risdate><volume>21</volume><issue>1</issue><spage>281</spage><epage>282</epage><pages>281-282</pages><issn>1107-0625</issn><cop>Greece</cop><pmid>27061562</pmid><tpages>2</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1107-0625 |
| ispartof | Journal of B.U. ON., 2016-01, Vol.21 (1), p.281-282 |
| issn | 1107-0625 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1780509979 |
| source | MEDLINE; EZB-FREE-00999 freely available EZB journals |
| subjects | Brain Neoplasms - secondary Carcinoma, Renal Cell - drug therapy Carcinoma, Renal Cell - secondary Humans Kidney Neoplasms - drug therapy Kidney Neoplasms - pathology Protein Kinase Inhibitors - therapeutic use Protein-Tyrosine Kinases - antagonists & inhibitors |
| title | The role of tyrosine kinase inhibitors in the treatment of renal cell carcinoma with brain metastases |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T15%3A17%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20role%20of%20tyrosine%20kinase%20inhibitors%20in%20the%20treatment%20of%20renal%20cell%20carcinoma%20with%20brain%20metastases&rft.jtitle=Journal%20of%20B.U.%20ON.&rft.au=Aytekin,%20Aydin&rft.date=2016-01&rft.volume=21&rft.issue=1&rft.spage=281&rft.epage=282&rft.pages=281-282&rft.issn=1107-0625&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E1780509979%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1780509979&rft_id=info:pmid/27061562&rfr_iscdi=true |